Home543064 • BOM
add
Cohance Lifesciences Ltd
Previous close
₹309.20
Day range
₹305.00 - ₹319.60
Year range
₹303.50 - ₹1,179.95
Market cap
117.85B INR
Avg Volume
124.27K
P/E ratio
53.23
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.45B | 77.29% |
Operating expense | 3.37B | 118.74% |
Net income | 367.20M | -55.69% |
Net profit margin | 6.74 | -75.02% |
Earnings per share | 0.55 | — |
EBITDA | 677.82M | -38.55% |
Effective tax rate | 28.52% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.00B | -38.94% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 39.25B | — |
Shares outstanding | 382.50M | — |
Price to book | 3.12 | — |
Return on assets | — | — |
Return on capital | 2.77% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 367.20M | -55.69% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,212
